Genmab stock rallies after Epkinly shows strong results in 2L lymphoma trial

Markets Investing.com By Investing.com 30 Jun 2026 08:22 1 min read

Genmab stock rallies after Epkinly shows strong results in 2L lymphoma trial

Genmab stock rallies after Epkinly shows strong results in 2L lymphoma trial

Genmab stock rallies after Epkinly shows strong results in 2L lymphoma trial

Read the full story on Investing.com → Opens the original article on www.investing.com

Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.